Quick Takeaways: Why It Matters? The $100M Symbiotic Capital facility, with $30M already drawn, gives TARGAN flexible, non‑dilutive growth capital, resets its lender base, and underwrites faster global deployment of WingScan at a time when revenues are already more th...
